The Department Memorandum 2021-0246 or the Implementation of “Pilot Study to Evaluate the Effectiveness and Safety of the Bedaquiline-Pretomanid-Linezolid (BPaL) Treatment Regimen in the Philippines” dated 18 May 2021 states that the 12 BPaL operational research sites will start enrolling patients on May 2021, and the TB laboratory network shall support the study.